Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-22

Clinical Trial Update: A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog® [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a liquid BioChaperone Insulin Lispro formulation versus Humalog for continuous subcutaneous insulin infusion in Type 1 diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioChaperone Insulin Lispro (insulin lispro)
  • Humalog (insulin lispro)

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED